• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

癌症患者中因子 XIII 活性和单核细胞衍生微粒的临床意义

Clinical Significance of Factor XIII Activity and Monocyte-Derived Microparticles in Cancer Patients.

作者信息

Sawai Yusuke, Yamanaka Yuta, Nomura Shosaku

机构信息

First Department of Internal Medicine, Kansai Medical University, Osaka, Japan.

出版信息

Vasc Health Risk Manag. 2020 Apr 1;16:103-110. doi: 10.2147/VHRM.S240500. eCollection 2020.

DOI:10.2147/VHRM.S240500
PMID:32280233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7131992/
Abstract

BACKGROUND

The aim was to evaluate factor XIII activity (FXIIIa) and monocyte-derived microparticles (MDMPs) in cancer patients.

METHODS

In total, 138 cancer patients (31 malignant lymphomas, 39 multiple myelomas, and 68 lung cancers) were analyzed. We measured various biomarkers including FXIIIa and MDMPs.

RESULTS

The values of endothelial activation markers, monocyte chemoattractant peptide (MCP)-1, soluble (s)CD14, and MDMPs were higher in cancer patients than in non-cancerous controls. MCP-1, sCD14, and MDMPs were significantly correlated with FXIIIa in multivariate analysis in cancer patients. In addition, MCP-1, sCD14, and MDMP levels were significantly increased in the high FXIIIa group of patients. Finally, the survival rate of the high FXIIIa group was significantly poor in the Kaplan-Meier analysis.

CONCLUSION

These results suggest that abnormal levels of FXIIIa and MDMPs may offer promise as poor prognostic factors in cancer patients.

摘要

背景

目的是评估癌症患者的凝血因子 XIII 活性（FXIIIa）和单核细胞衍生的微粒（MDMPs）。

方法

总共分析了 138 名癌症患者（31 例恶性淋巴瘤、39 例多发性骨髓瘤和 68 例肺癌）。我们测量了包括 FXIIIa 和 MDMPs 在内的各种生物标志物。

结果

癌症患者体内内皮细胞活化标志物、单核细胞趋化蛋白（MCP）-1、可溶性（s）CD14 和 MDMPs 的值高于非癌症对照。在癌症患者的多变量分析中，MCP-1、sCD14 和 MDMPs 与 FXIIIa 显著相关。此外，FXIIIa 水平高的患者组中 MCP-1、sCD14 和 MDMP 水平显著升高。最后，在 Kaplan-Meier 分析中，FXIIIa 水平高的患者组生存率显著较差。

结论

这些结果表明，FXIIIa 和 MDMPs 的异常水平可能有望作为癌症患者预后不良的因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec1/7131992/7ab7b7ad4538/VHRM-16-103-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec1/7131992/76fc89359cd1/VHRM-16-103-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec1/7131992/7ab7b7ad4538/VHRM-16-103-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec1/7131992/76fc89359cd1/VHRM-16-103-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec1/7131992/7ab7b7ad4538/VHRM-16-103-g0002.jpg

相似文献

1
Clinical Significance of Factor XIII Activity and Monocyte-Derived Microparticles in Cancer Patients.癌症患者中因子 XIII 活性和单核细胞衍生微粒的临床意义
Vasc Health Risk Manag. 2020 Apr 1;16:103-110. doi: 10.2147/VHRM.S240500. eCollection 2020.
2
Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus.2型糖尿病患者中单核细胞衍生微粒的检测
Diabetologia. 2002 Apr;45(4):550-5. doi: 10.1007/s00125-001-0772-7.
3
Endothelial cell-, platelet-, and monocyte/macrophage-derived microparticles are elevated in psoriasis beyond cardiometabolic risk factors.银屑病患者的内皮细胞、血小板和单核细胞/巨噬细胞来源的微颗粒水平升高，超出了心血管代谢危险因素的范围。
J Am Heart Assoc. 2014 Feb 28;3(1):e000507. doi: 10.1161/JAHA.113.000507.
4
Significance of anti-oxidized LDL antibody and monocyte-derived microparticles in anti-phospholipid antibody syndrome.抗氧化低密度脂蛋白抗体和单核细胞衍生微粒在抗磷脂抗体综合征中的意义。
Autoimmunity. 2003 May;36(3):125-31. doi: 10.1080/0891693031000079257.
5
Factor XIII and inflammatory cells.凝血因子 XIII 与炎症细胞。
Thromb Res. 2012 May;129 Suppl 2:S77-81. doi: 10.1016/j.thromres.2012.02.040. Epub 2012 Mar 15.
6
Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients.癌症患者的血小板和微粒混合样本中的组织因子活性增加。
Thromb Res. 2008;122(5):604-9. doi: 10.1016/j.thromres.2007.12.023. Epub 2008 Feb 11.
7
Monocyte-derived microparticles may be a sign of vascular complication in patients with lung cancer.单核细胞衍生的微粒可能是肺癌患者血管并发症的一个迹象。
Lung Cancer. 2003 Feb;39(2):145-9. doi: 10.1016/s0169-5002(02)00441-5.
8
Correlation and association between plasma platelet-, monocyte- and endothelial cell-derived microparticles in hypertensive patients with type 2 diabetes mellitus.高血压合并 2 型糖尿病患者血浆血小板、单核细胞和内皮细胞来源的微颗粒的相关性和关联性。
Platelets. 2009 Sep;20(6):406-14. doi: 10.1080/09537100903114545.
9
Effects of normoxic and hypoxic exercise regimens on monocyte-mediated thrombin generation in sedentary men.常氧和低氧运动方案对久坐男性单核细胞介导的凝血酶生成的影响。
Clin Sci (Lond). 2015 Aug;129(4):363-74. doi: 10.1042/CS20150128.
10
Significance of microparticles in progressive systemic sclerosis with interstitial pneumonia.微粒在伴有间质性肺炎的进行性系统性硬化症中的意义。
Platelets. 2008 May;19(3):192-8. doi: 10.1080/09537100701882038.

引用本文的文献

1
Haemostatic Gene Expression in Cancer-Related Immunothrombosis: Contribution for Venous Thromboembolism and Ovarian Tumour Behaviour.癌症相关免疫血栓形成中的止血基因表达：对静脉血栓栓塞和卵巢肿瘤行为的作用
Cancers (Basel). 2024 Jun 27;16(13):2356. doi: 10.3390/cancers16132356.
2
Transglutaminases are oncogenic biomarkers in human cancers and therapeutic targeting of TGM2 blocks chemoresistance and macrophage infiltration in pancreatic cancer.转谷氨酰胺酶是人类癌症中的致癌生物标志物，靶向TGM2进行治疗可阻断胰腺癌的化疗耐药性和巨噬细胞浸润。
Cell Oncol (Dordr). 2023 Oct;46(5):1473-1492. doi: 10.1007/s13402-023-00824-7. Epub 2023 May 29.
3

本文引用的文献

1
Biology and Role of Extracellular Vesicles (EVs) in the Pathogenesis of Thrombosis.细胞外囊泡（EVs）在血栓形成发病机制中的生物学作用和角色。
Int J Mol Sci. 2019 Jun 11;20(11):2840. doi: 10.3390/ijms20112840.
2
Mean platelet volume as a prognostic factor for venous thromboembolic disease.平均血小板体积作为静脉血栓栓塞性疾病的一个预后因素。
Rev Med Chil. 2019 Feb;147(2):145-152. doi: 10.4067/s0034-98872019000200145.
3
Increased coagulation factor XIII activity but not genetic variants of coagulation factors is associated with myocardial infarction in young patients.
Identification of novel biomarkers differentially expressed between African-American and Caucasian-American prostate cancer patients.
非裔美国人和欧裔美国前列腺癌患者之间差异表达的新型生物标志物的鉴定。
Am J Cancer Res. 2022 Apr 15;12(4):1660-1670. eCollection 2022.
4
Coagulation Factor XIII Subunit A Is a Biomarker for Curative Effects and Prognosis in Malignant Solid Tumors, Especially Non-small Cell Lung Cancer.凝血因子 XIII A 亚基是恶性实体瘤尤其是非小细胞肺癌治疗效果和预后的生物标志物。
Front Oncol. 2021 Dec 15;11:719085. doi: 10.3389/fonc.2021.719085. eCollection 2021.
5
The Relationship Between Thrombo-Inflammatory Biomarkers and Cellular Indices of Inflammation in Lymphoma Patients.淋巴瘤患者血栓炎症生物标志物与炎症细胞指标的关系。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211050358. doi: 10.1177/10760296211050358.
6
Increased expression of IFI16 predicts adverse prognosis in multiple myeloma.IFI16 表达增加预示多发性骨髓瘤不良预后。
Pharmacogenomics J. 2021 Aug;21(4):520-532. doi: 10.1038/s41397-021-00230-y. Epub 2021 Mar 12.
凝血因子 XIII 活性增加而非凝血因子的遗传变异与年轻患者的心肌梗死有关。
J Thromb Thrombolysis. 2019 Oct;48(3):519-527. doi: 10.1007/s11239-019-01856-3.
4
Prediction of Ischemic Events after Percutaneous Coronary Intervention: Thrombelastography Profiles and Factor XIIIa Activity.经皮冠状动脉介入治疗后缺血事件的预测：血栓弹力图特征与凝血因子XIIIa活性
TH Open. 2018 Apr;2(2):e173-e181. doi: 10.1055/s-0038-1645876.
5
Mechanism and Management of Cancer Chemotherapy-Induced Atherosclerosis.癌症化疗诱导的动脉粥样硬化的机制与管理。
J Atheroscler Thromb. 2018 Oct 1;25(10):994-1002. doi: 10.5551/jat.RV17027. Epub 2018 Sep 14.
6
The Cardiologist and the Cancer Patient: Challenges to Cardio-Oncology (or Onco-Cardiology) and Call to Action.心脏病专家与癌症患者：心脏肿瘤学（或肿瘤心脏病学）面临的挑战及行动呼吁
J Am Coll Cardiol. 2018 Jul 10;72(2):228-232. doi: 10.1016/j.jacc.2018.04.043.
7
Differential Interaction of Platelet-Derived Extracellular Vesicles with Leukocyte Subsets in Human Whole Blood.血小板衍生的细胞外囊泡在人全血中与白细胞亚群的差异相互作用。
Sci Rep. 2018 Apr 26;8(1):6598. doi: 10.1038/s41598-018-25047-x.
8
Tissue Factor-bearing MPs and the risk of venous thrombosis in cancer patients: A meta-analysis.载有组织因子的 MPs 与癌症患者静脉血栓形成风险：一项荟萃分析。
Sci Rep. 2018 Jan 26;8(1):1675. doi: 10.1038/s41598-018-19889-8.
9
Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2.癌症治疗的心血管并发症：诊断、预防及管理的最佳实践：第2部分
J Am Coll Cardiol. 2017 Nov 14;70(20):2552-2565. doi: 10.1016/j.jacc.2017.09.1095.
10
Advances of Coagulation Factor XIII.凝血因子 XIII 的研究进展
Chin Med J (Engl). 2017 Jan 20;130(2):219-223. doi: 10.4103/0366-6999.198007.